4'-Methylene-5,8,10-trideazaaminopterin Uses, Dosage, Side Effects and more
CH-1504 is a an antirheumatic agent that has been shown in vitro to be a nonpolyglutamylatable and nonhydroxylatable antifolate that is more efficiently taken up into cells by the reduced folate carrier (RFC) system than is Methotrexate. It has been investigated for the treatment of Rheumatoid Arthritis (phase II).
| Attribute | Details |
|---|---|
| Trade Name | 4'-Methylene-5,8,10-trideazaaminopterin |
| Generic | 4'-Methylene-5,8,10-trideazaaminopterin |
| Type | |
| Formula | C23H23N5O5 |
| Weight | Average: 449.467 Monoisotopic: 449.169918861 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in inflammatory disorders (unspecified), psoriasis and psoriatic disorders, and rheumatoid arthritis.
